On Tuesday, Hong Kong-listed CRO-related stocks fell sharply across the board. GENSCRIPT BIO plunged more than 18% during intraday trading, PHARMARON dropped over 8%, TIGERMED and JOINN declined more than 7%, WUXI BIO fell over 6%, VIVA BIOTECH dropped more than 5%, WUXI APPTEC declined over 4%, and ASYMCHEM fell more than 3%.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.